In summary, although LRRC41 holds promise as a prognostic biomarker and therapeutic target for HCC, further investigations are warranted to elucidate the underlying molecular mechanisms regulating LRRC41-mediated HCC progression. This evidence concerns the gene LRRC41 and hepatocellular carcinoma.